CorLyst Group

CorLyst Group is a professional services firm offering strategic consulting and advisory to businesses seeking corporate growth and operational excellence. The company provides expertise in areas such as mergers and acquisitions, new venture incubation, and comprehensive portfolio management, leveraging a team of seasoned entrepreneurs and corporate development specialists. Their approach focuses on guiding companies through various stages of expansion and market penetration.

The firm was founded in 2015 by Dr. David Young, who serves as President and CEO. Dr. Young brings over three decades of experience in pharmaceutical research, drug development, and corporate leadership to the organization. He established CorLyst Group based on the insight that many emerging and mid-market companies could benefit from the practical, hands-on guidance of experienced operators who have successfully built and scaled businesses.

CorLyst Group serves a diverse clientele ranging from domestic start-ups to established middle-market companies, with a particular emphasis on the pharmaceutical and life sciences sectors. The company's long-term vision centers on empowering client organizations to achieve their strategic objectives and unlock their full potential, providing the critical support necessary for successful navigation of complex business landscapes and sustained value creation.